Filing Details
- Accession Number:
- 0001209191-14-037656
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-29 17:26:18
- Reporting Period:
- 2014-05-27
- Filing Date:
- 2014-05-29
- Accepted Time:
- 2014-05-29 16:26:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375211 | M Timothy Sullivan | C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139 | Vp Development Programs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-27 | 73,499 | $1.16 | 98,413 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-05-27 | 87,100 | $0.69 | 185,513 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-05-27 | 160,599 | $2.73 | 24,914 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2014-05-27 | 73,499 | $0.00 | 73,499 | $1.16 |
| Common Stock | Stock Option | Disposition | 2014-05-27 | 87,100 | $0.00 | 87,100 | $0.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 36,001 | 2013-11-28 | 2021-11-28 | No | 4 | M | Direct |
| 130,650 | 2014-05-22 | 2023-05-22 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $2.70 to $2.795, inclusive. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer or a securityholder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
